Cartesian Therapeutics (RNAC) Q3 2025 Earnings

Aug 7Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.13
-0.59
-0.04
0.5

Details

Expected EPS
-0.802911
Actual EPS
0.5
Surprise EPS
1.3
Surprise Percent
+162.27%

Description

⁨Cartesian Therapeutics⁩ (⁦RNAC⁩) has reported earnings of ⁦0.5⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts